Compare ABSI & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABSI | FINV |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 1.2B |
| IPO Year | 2021 | 2017 |
| Metric | ABSI | FINV |
|---|---|---|
| Price | $8.65 | $3.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.96 | ★ $12.10 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 6.09% |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $215.96 | N/A |
| Revenue Next Year | $319.10 | $10.58 |
| P/E Ratio | ★ N/A | $3.87 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $3.22 |
| 52 Week High | $12.06 | $8.05 |
| Indicator | ABSI | FINV |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 29.87 |
| Support Level | $8.55 | $3.22 |
| Resistance Level | $10.03 | $5.17 |
| Average True Range (ATR) | 0.55 | 0.22 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 23.35 | 11.52 |
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.